You are here

  • Home
  • Archive
  • Volume 90, Issue 5
  • Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial

Article metrics

Article menu

Download PDFPDF

Neurogenetics
Research paper
Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial

 

Online download statistics by month:

Online download statistics by month: April 2018 to March 2024

AbstractFullPdf
Apr 2018768793209
May 201864770495
Jun 201825325955
Jul 201826626769
Aug 201818118156
Sep 201813913965
Oct 201814014050
Nov 201814914943
Dec 201827627661
Jan 201926226276
Feb 201937437478
Mar 2019430429140
Apr 2019584580207
May 2019349347149
Jun 2019254253103
Jul 201926626666
Aug 201916416343
Sep 201920019927
Oct 201918818848
Nov 201914314351
Dec 201929429450
Jan 202013813845
Feb 202023723083
Mar 202020820364
Apr 202021721296
May 202012511666
Jun 202013112863
Jul 202029328078
Aug 202012011065
Sep 202013713241
Oct 202014413566
Nov 202014513848
Dec 202021020352
Jan 202124823893
Feb 202110610457
Mar 202119618470
Apr 202120519587
May 202124824172
Jun 202116916391
Jul 202118918951
Aug 202121721554
Sep 202120919955
Oct 202118817978
Nov 202116915780
Dec 202117617655
Jan 202214614341
Feb 202216815954
Mar 202222823554
Apr 202216414758
May 202215714970
Jun 202211810847
Jul 202213712749
Aug 202214914172
Sep 202214113756
Oct 202216515855
Nov 202211310647
Dec 20221049429
Jan 202313712749
Feb 202315315144
Mar 202313112742
Apr 2023706937
May 2023888844
Jun 202321619136
Jul 202311010342
Aug 202322221245
Sep 202315015454
Oct 202315414747
Nov 202316515247
Dec 202317714856
Jan 202415413949
Feb 202415714150
Mar 2024139128129
Total14765144524754